Women and Health. Edition No. 3

Table of Contents

Part I: Women, health, and medicine
Section 1: Introduction to women’s health

1. Women’s health in the third decade of the 21st century
2. The journey to the 21st century
3. Current approaches to women’s health care
4. The impact of health coverage on women’s access to care in the United States
5. Complementary and integrative medicine and women’s health
6. Racial and/or ethnic disparities in women’s health
7. Weathering: the mutability of women’s health with age and the consequences of injustice
8. Sexual minority women’s health
9. Research regarding the health of transgender and nonbinary populations
10. Women’s health across the life course in low and middle income countries: an urgent and unfinished agenda
11. Migrant and refugee health: the influence of context and assets on women’s health across the lifecourse

Section 2: Research methods in women’s health

12. Understanding research designs
13. The evolving focus of women’s health research
14. Life course approach to research in women’s health
15. Principles of genetics and genomics
16. Omic technologies and Precision Women’s Health

Section 3: Introduction to the social (and structural) determinants of women’s health

17. Women, stress, and health
18. Intimate partner violence
19. Social policy choices, women, and health
20. The impact of the built environment on health
21. Women’s health and the carceral state

Part II: Sexual and reproductive health
Section 4: Sexual and reproductive health, third edition, Women and Health

22. Puberty development: determinants and health impacts
23. Menstruation and menstrual disorders
24. Premenstrual disorders
25. Contraception
26. Induced abortion
27. Infertility
28. Medically assisted reproduction
29. Labor and childbirth
30. Pregnancy complications and future maternal health
31. Epidemiology of endometriosis and adenomyosis
32. Uterine leiomyomata
33. Female sexuality and sexual function
34. Vulvodynia
35. The epidemiology of menopause
36. Overview of pelvic floor disorders: epidemiology, diagnosis, and treatment
37. Hysterectomy: global patterns and public health priorities
38. Female genital cutting

Section 5: Infections

39. Gonococcal infection in women
40. Chlamydia trachomatis
41. Syphilis in women
42. Vaginal infections
43. Urinary tract infection
44. Genital herpes
45. Human immunodeficiency virus and acquired immunodeficiency syndrome in women
46. Human papilloma virus infection in women
47. Pelvic inflammatory disease and chronic pelvic pain
48. Hepatitis C infection in women
49. Malaria

Part III: Occupation and environmental health
Section 6: Occupational and environmental determinants of health

50. Working women in the United States: a statistical profile
51. International perspectives: women’s occupational health
52. Multiple roles and complex exposures
53. Reproductive hazards of environmental and occupational exposures
54. Work related musculoskeletal disorders
55. Occupational cancer
56. Environmental exposures and cancer

Part IV: Chronic disease
Section 7: Cardiovascular disease in women

57. Overview of risk factors for cardiovascular disease
58. Lipids in women: lifelong risk assessment
59. Hypertension in women
60. Emotions and cardiovascular disease in women
61. Diagnosis and treatment of ischemic heart disease in women
62. Cerebrovascular disease in women
63. Heart failure in women: epidemiology, prognosis, and management
64. Atrial fibrillation and sudden cardiac death in women
65. Venous thromboembolism in women: insights into epidemiology, risk factors, and clinical management

Section 8: Cancer

66. The impact of sex and gender on nonreproductive cancers
67. Cancer in women: global burden and insights from gender comparisons
68. Epidemiology of breast cancer
69. Current issues in breast cancer screening
70. Ovarian cancer
71. Endometrial cancer
72. Cervical cancer: burden of disease and risk factors
73. Screening and vaccination in cervical cancer control and prevention
74. Lung cancer in women-epidemiology and risk factors
75. Colorectal cancer in women
76. The epidemiology of melanoma of the skin
77. Women and health cancer prevention

Section 9: Autoimmune and immune mediated diseases-heterogeneous, multisystem disorders

78. Multiple sclerosis
79. Rheumatoid arthritis
80. Systemic lupus erythematosus
81. Sarcoidosis
82. Inflammatory bowel disease
83. Asthma

Section 10: Endocrinology and women’s health

84. The obesity epidemic and women’s health
85. Polycystic ovary syndrome
86. Diabetes in women
87. Thyroid disease and women
88. Management of menopausal symptoms
89. Osteoporosis

Part V: Behavioral and inadequately characterized conditions
Section 11: Behavioral health and psychiatric disorders-introduction

90. Gender and mood disorders
91. Anxiety disorders in women
92. Posttraumatic stress disorder in women
93. Psychosis in women: gender differences in presentation, onset, course, and outcome of schizophrenia
94. Eating disorders in women
95. Drug use disorders in women
96. Alcohol use disorder in women
97. Women’s health and tobacco

Section 12: Pain, inflammation, and fatigue

98. Complex regional pain syndrome in women
99. Fibromyalgia
100. Multiple chemical sensitivity
101. Overview of headache disorders in women: emphasis on older adults
102. Irritable bowel syndrome
103. Myalgic encephalomyelitis/chronic fatigue syndrome

Part VI: Aging
Section 13: Aging

104. Morbidity, disability, and mortality
105. Urinary and fecal incontinence in older women
106. Hearing loss and aging
107. Visual impairment in older women
108. Women’s oral health: a life course approach to oral health
109. Cognitive functioning and dementia in aging women
110. The role of social support on health and well being in older adult widows
111. Long term care: the global impact on women
112. Caring for women with serious illness
113. Successful aging in women
114. Frailty in older women
115. Musculoskeletal disorders: focus on osteoarthritis

Authors

Rebecca Troisi Epidemiologist, Staff Scientist, National Cancer Institute, National Institute of Health (NIH) USA. Dr. Rebecca Troisi is a research epidemiologist with expertise and extensive experience in the areas of reproductive health, cancer, and life course epidemiology at the Division of Cancer Epidemiology and Genetics, National Cancer Institute. Dr. Troisi leads the Diethylstilbestrol Follow-up Study and has many domestic and international collaborations including the Nordic Project. As well as having co-edited the second edition of Women and Health, she has authored over 150 peer-reviewed publications, many as first or last author, and several book chapters. Her current position at the National Institute of Health includes collaboration with the Office of Research on Women's Health providing an overview and big picture regarding current issues and initiatives in this area. Kathryn Rexrode Chief, Division of Women's Health, Department of Medicine, Brigham and Women's Hospital, USA. Dr. Kathryn Rexrode is the Chief of the Division of Women's Health in the Department of Medicine at Brigham and Women's Hospital (BWH) and an Associate Professor of Medicine at Harvard Medical School. Dr. Rexrode is a general internist and has broad and deep research experience in women's health, with a particular expertise in cardiovascular disease in women. She leads multiple grants from the National institute of Health and is the author of more than 250 research publications. Dr. Rexrode is a Fellow of the American Heart Association and Chair of the Women and Special Populations Committee. Yvette Cozier Associate Professor, Department of Epidemiology, Boston University School of Public Health, USA. Dr. Yvette Cozier is an Associate Professor of Epidemiology, and the Associate Dean of Diversity, Equity, Inclusion and Justice (DEIJ) at Boston University School of Public Health. She is also a Senior Epidemiologist at the Slone Epidemiology Center at Boston University School of Medicine. A social epidemiologist, Dr. Cozier's overall research focus has been on the influence of psychosocial and structural factors on health - including racism and neighborhood socioeconomic status (SES). Dr. Cozier co-leads (MPI) the Black Women's Health Study (BWHS), a prospective follow-up of over 59,000 African American women begun in 1995. She has published over 100 abstracts, manuscripts, invited commentaries and reviews, monographs, and book chapters on health disparities, cardiometabolic, and immune-mediated conditions including obesity, lupus, and sarcoidosis. Marlene B. Goldman Emerita Professor, Department of Obstetrics and Gynecology, Geisel School of Medicine at Dartmouth, USA. Dr. Goldman's career spans more than thirty-five years and includes extensive experience in research design, methodology, and analysis. As Director of Clinical Research, she supervised faculty and resident research in reproductive endocrinology and infertility, maternal-fetal medicine, urogynecology, and gynecologic oncology. Dr. Goldman completed graduate and post-graduate study in epidemiology at Harvard University's School of Public Health where she also served on the faculty for more than a decade. During the development of the first edition of Women & Health she received a Health Sciences Fellowship at the Radcliffe Institute for Advanced Study at Harvard University. Dr. Goldman is a Fellow of the American College of Epidemiology and a lifetime member of the American Society for Reproductive Medicine. She was previously an Associate Editor of the American Journal of Epidemiology, a chartered member of the NIH IRAP study section, and an Investigator in the Cancer Epidemiology and Chemoprevention Research program at Dartmouth's Norris Cotton Cancer Center.